Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro
✍ Scribed by Hairong Song; Marina Vita; Hatem Sallam; Ramin Tehranchi; Christina Nilsson; Åke Sidén; Zuzana Hassan
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 416 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract CDK2 inhibitors have been proposed as effective anti‐cancer therapeutics. We show here that CYC202 (__R__‐roscovitine) is a potent inhibitor of recombinant CDK2/cyclin E kinase activity (IC~50~ = 0.10 μM) with an average cytotoxic IC~50~ of 15.2 μM in a panel of 19 human tumour cell lin
Hepatic progenitor cells (called oval cells in rodents) proliferate during chronic liver injury. They have been suggested as targets of malignant transformation in chronic liver diseases, including chronic hepatitis C. Interferon alpha therapy reduces the risk of hepatocellular carcinoma (HCC) in ch